The last enzyme in the arginine-biosynthesis pathway, argininosuccinate lyase, from Mycobacterium tuberculosis has been cloned, expressed, purified and crystallized, and preliminary X-ray studies have been carried out on the crystals. The His-tagged tetrameric enzyme with a subunit molecular weight of 50.9 kDa crystallized with two tetramers in the asymmetric unit of the orthorhombic unit cell, space group P2 1 2 1 2 1 . Molecular-replacement calculations and self-rotation calculations confirmed the space group and the tetrameric nature of the molecule.
Introduction
We have been pursuing a long-range programme of structural studies of proteins from Mycobacterium tuberculosis and related organisms with a view to contributing to the understanding of the basic biology of the pathogen and to build a platform for structure-based inhibitor design (Vijayan, 2005; Arora et al., 2011; Abhinav et al., 2013) . Much of our work has been concerned with DNA recombination, protein synthesis and stringent response (Vijayan, 2005; Krishna et al., 2007; Selvaraj et al., 2007; Kaushal et al., 2008; Roy et al., 2008; Prabu et al., 2009; Chandran et al., 2010) . Biosynthetic pathways offer another attractive area for structural investigation. In this context, we have already carried out detailed studies on pantothenate kinase, the first enzyme in the CoA-biosynthetic pathway, from M. tuberculosis (Das et al., 2006; Chetnani et al., 2009 Chetnani et al., , 2010 Chetnani et al., , 2011 . We have now initiated work on selected proteins in the pathway involved in the biosynthesis of arginine.
The biosynthesis of arginine, which is essential for the growth, survival and sustenance of many eubacteria, involves eight steps, in the first of which l-glutamic acid is converted to N-acetyl-l-glutamic acid with the concurrent conversion of acetyl-CoA to CoA. In the final step, l-argininosuccinate is converted in an elimination reaction into arginine and fumaric acid by the enzyme argininosuccinate lyase, which is the subject of the present study. Argininosuccinate lyase is a 470-amino-acid enzyme with a molecular mass of 49.7 kDa that is essential in M. tuberculosis (Griffin et al., 2011) . Crystal structures of the enzyme from Escherichia coli (Bhaumik et al., 2004) , Thermus thermophilus (PDB entry 2e9f; M. Goto, unpublished work), Anas platyrhynchos (Sampaleanu et al., 2001) , A. anser (Lee et al., 2005) , Meleagris gallopavo (Sampaleanu et al., 2001) and Homo sapiens (Turner et al., 1997) have been determined. Here, we report the preliminary biochemical and crystallographic studies of the enzyme from M. tuberculosis.
Materials and methods

Cloning, expression and purification
The argininosuccinate lyase or ArgH (Rv1659) open reading frame was amplified by PCR using M. tuberculosis H37Rv genomic DNA (Cole et al., 1998) . The sequence of the forward primer used was 5 0 -CTCGCCACCATATGATGAGCACCAACGAGGGGTC-3 0 (NdeI restriction site in bold) and that of the reverse primer was 5 0 -GAGGCCCTCGAGGCGCACCAGCTGGC-3 0 (XhoI restriction site in bold). PCR involved 30 cycles comprising of denaturation at 368 K (1 min), annealing at 337 K (1 min) and extension at 345 K (1 min). The NdeI-XhoI flanking fragment consisting of a 1413 bp argH open reading frame was then cloned into pET-22b(+) vector. Recombinant cloning was performed using NdeI and XhoI endonucleases and the integrity of the DNA sequence was established by sequencing. The recombinant construct thus obtained, pET22b-Rv1659 (NdeI-XhoI), with an extra methionine at the N-terminus and an extended sequence LEHHHHHH at the C-terminus of Rv1659, was employed for protein overexpression.
ArgH protein tagged with a C-terminal hexahistidine stretch was then expressed in E. coli strain BL21 (DE3) under the influence of a T7 promoter. Cells transformed with the recombinant plasmid were grown in Luria-Bertani medium supplemented with 100 mg ml À1 ampicillin at 310 K. When the A 600 reached 0.6, the culture was induced with 0.5 mM isopropyl -d-1-thiogalactopyranoside (IPTG) and was incubated for a further 3 h. The cells were harvested by centrifugation at 6000 rev min À1 for 10 min at room temperature. The pellet was washed with phosphate-buffered saline and was then resuspended in ice-cold lysis buffer (30 mM Tris-HCl pH 8, 500 mM NaCl, 2 mM PMSF, 2 mM -mercaptoethanol). The solution was then sonicated at 25% amplitude for 5 min with an on-off cycle of 2 and 5 s, respectively. The lysate was centrifuged at 14 000 rev min À1 for 45 min at 277 K. The recombinant ArgH protein with the hexa-His tag in the supernatant was purified using an Ni-NTA metal affinity column (Novagen). The supernatant was left to bind to the column for 45 min, followed by subsequent washing with lysis buffer containing 20, 40 and 60 mM imidazole. The protein was then eluted with an elution buffer consisting of lysis buffer containing 100, 200 and 300 mM imidazole, respectively, as a competitor. The protein was further dialyzed against 25 mM potassium phosphate buffer and stored in the same buffer at 277 K. The final yield of the protein was 15 mg per litre of culture.
The purity of the protein, which had a molecular mass of 50.9 kDa including the hexahistidine tag, was determined by SDS-PAGE analysis (Fig. 1) . Native PAGE and gel-filtration experiments were carried out to confirm the quaternary association.
Crystallization
The microbatch-under-oil method was employed for all crystallization experiments, using Greiner 72-well plates with equal proportions of silicon and paraffin oil. Various conditions were screened using commercially available kits from Hampton Research, Molecular Dimensions and Jena Biosciences. All drops consisted of 2 ml protein solution (9.5 mg ml À1 ) in 25 mM phosphate buffer pH 7.4 and 2 ml precipitant solution. Somewhat irregularly shaped diffractionquality crystals (0.05 Â 0.05 Â 0.15 mm) were obtained from Index (Hampton Research) condition No. 42 in about 45 d at 295 K (Fig. 2) . The precipitant solution consisted of 100 mM bis-tris pH 5.5, 25%(w/v) polyethylene glycol 3350.
X-ray data collection and processing
Intensity data were initially collected to 2.9 Å resolution at 100 K using a MAR 345 image plate mounted on a Bruker MICROSTAR ULTRA II Cu K rotating-anode X-ray generator. Subsequently, a 2.4 Å resolution data set could be collected using synchrotron radiation on the BM14 beamline at the ESRF using a MAR CCD detector, again at 100 K. No separate cryoprotectant was required during data collection. The diffraction data thus obtained were is the ith observation of reflection hkl, hI(hkl)i is the weighted average intensity for all i observations of the reflection with indices hkl and N(hkl) is the multiplicity. processed using MOSFLM (Leslie, 2006) and scaled using SCALA (Evans, 1993) from the CCP4 suite (Winn et al., 2011) . Crystal data and data-collection statistics are given in Table 1 .
Molecular replacement and rotation function
Molecular-replacement calculations were carried out using Phaser (McCoy et al., 2007) , while MOLREP (Vagin & Teplyakov, 2010) was used for evaluating the self-rotation function.
Results and discussion
Argininosuccinate lyase from M. tuberculosis with a hexahistidine tag has been purified to homogeneity (Fig. 1) . The tetrameric molecule has a subunit molecular mass of 50.9 kDa. The protein has been crystallized ( Fig. 2) and preliminary X-ray analysis of the crystals has been carried out. A value of 2.65 Å 3 Da À1 for the Matthews coefficient (Matthews, 1968) suggested the presence of two tetrameric molecules in the asymmetric unit of the orthorhombic cell. Systematic absences clearly indicated the space group to be P2 1 2 1 2 1.
The Molecular-replacement calculations with the tetrameric enzyme from T. thermophilus as the search model led to an acceptable structure solution with a log-likelihood gain of 2771 and a Z-score of 53, thus confirming the space group. The results of the calculations were consistent with the self-rotation function, indicating the tetrameric nature of the molecule with 222 symmetry. X-ray intensity data were collected at the Facility for Protein X-ray Crystal Structure Determination and Protein Design at the Indian Institute of Science, supported by the Department of Science and Technology, and on the BM14 beamline at the ESRF, Grenoble, supported by EMBL and the Department of Biotechnology and manned by Dr Hassan Belrhali and Dr Babu A. Manjasetty. Financial support to AS from the Indian Council of Medical Research (ICMR No. 5/8/5/6/2012/ECD-1) is acknowledged. AM is a Junior Research Fellow of the Council of Scientific and Industrial Research (CSIR).
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